Analisis Hubungan Kepatuhan Pengobatan Terhadap Kontrol Glikemik Pasien Diabetes Melitus Tipe 2di Instalasi Rawat Jalan Rumah Sakit “X”buleleng

Abstract

Type 2 Diabetes mellitus (T2DM) is a chronic disease that requires long-term treatment. There were problems related to antidiabetic medication adherence. Medication adherence directly affects patient’s blood glucose level. The aim of this study was to analyze the association between the medication adherence and glycemic control among T2DM patients. The study was an observational with cross sectional design. Participants were 90 of T2DM outpatient at “X” Buleleng General Hospital in July-September 2020. T2DM patients were included if age ?18 years, received the same antidiabetic for three months before the study, sign informed consent, fill out the questionnare and have fully medical record data. Patient are excluded if having weak general condition, were pregnant or breastfeeding. Data was collected through interview using the Probabilistic Medication Adherence Scale (ProMAS) questionnaire and based on patient’s medical records. Data were analyzed with Kruskall-Wallis test. The results showed that most of patients were male (55.6%), aged 46-65 years (61.1%), had DM for 5-10 years (46.7%), elementary school (37.8%), with comordbidities (50%) and without complications (77.8%). Majority of patients (42.2%) showed moderate-high medication adherence and the majority of patients (66.7%) has uncontrolled blood glucose. Based on statistical tests, there was no association between medication adherence with patient’s glycemic control (p=0.168). In dispite of it, finding showed that the level of medication adherence had an impact on glycemic control. Patients with high medication adherence showed better glycemic control.

Medication Compliance in Type 2 Diabetes Patients: HbA1c and Lipid Profile at Aulia Jombang Clinic 2020

“…Based on these results, it can be concluded that there is a relationship between the level of medication adherence in PRB patients diagnosed with diabetes mellitus and Total Cholesterol Lipid Profile levels. This is supported by research conducted by Rdeliani et al (2021) which said that the higher the level of adherence of a patient to treatment, the better glycemic control would be-also supported by research Wang (S. Wang, Ji, Zhang, & Xue, 2020) which says that glycemic control of HbA1c has a positive correlation with total cholesterol. So, if the glycemic control is reasonable, the whole cholesterol level will also be more optimal.…”

“…So, if the glycemic control is reasonable, the whole cholesterol level will also be more optimal. If the patient's adherence to is poor, it will cause glycemic control on HbA1c levels in these patients to become uncontrollable (Rdeliani et al, 2021). Poor glycemic control can cause an increase in blood glucose levels due to the inability to store sugar in the muscles and as glycogen in the liver.…”

Hubungan Health Locus of Control Terhadap Tingkat Kepatuhan Kontrol Glikemik Pada Pasien Diabetes Melitus Tipe 2 di Puskesmas Terminal Banjarmasin

“…World Health Organization (WHO) total penderita diabetes di Indonesia diperkirakan akan meningkat lebih dari dua kali lipat pada tahun 2030, dari perkiraan 8,4 juta pada tahun 2000 menjadi 21,3 juta (Nugroho et al, 2021). Indonesia menduduki urutan ke 7 ditahun 2018 dengan total penderita diabetes melitus sebanyak 14,4 juta penduduk dan diperkirakan akan terus meningkat antara tahun 2030 dan 2045 (Kementerian Kesehatan RI, 2019 dan International Diabetes Federation (IDF) dalam (Ardeliani et al, 2021)).…”